The processing of the raw mass spectral data differs in this report due to the genome sequence annotation specific to strain ATCC 33277 [11], [GenBank: AP009380] which served as the basis for a new ORF NU7026 solubility dmso database prepared by LANL (Los Alamos National Laboratory, Gary Xie, private communication). The custom database prepared by LANL was combined with reversed sequences from P. gingivalis ATCC 33277, human and bovine proteins as with our W83 database [GenBank: AE015924] described previously. The total size of the combined fasta file was 116 Mbytes. The estimated random qualitative FDR for peptide identifications based on the decoy strategy [35, 36] was

3%. Assignment of ORF numbers Additional file 1: Table S1 is arranged in ascending order by PGN numbers assigned for the experimental strain used here by Naito et al. [11]. They have been cross referenced to the W83 PG numbers originally assigned both by TIGR-CMR and LANL, where it was possible to do so. Certain ATCC

33277 genes do not have a counterpart in the older annotations based on the W83 genome, and will thus be blank in the summary table for PG numbers. DAVID An overall list of detected proteins as well as lists of proteins that showed increased or decreased levels between internalized and gingival growth medium cultured cells were prepared using Entrez gene identifiers, as DAVID [17] does not recognize PGN numbers. Ontology analyses were then conducted using the DAVID functional annotation clustering feature with the default databases. Both increased and decreased protein level

VX-661 in vivo lists were analyzed using the overall list of detected proteins as the background. Potentially interesting clusters identified by DAVID were then examined manually. Acknowledgements The authors wish to thank the Institute for Systems Biology for advice concerning the pathway analysis and LANL-ORALGEN for the machine readable fasta database. This work was supported by the NIH NIDCR under grants DE014372 and DE11111. Additional HKI-272 concentration funding was provided by the UW Office of Research, Unoprostone College of Engineering and the Department of Chemical Engineering. We thank Fred Taub for the FileMaker database. Electronic supplementary material Additional file 1: This file contains explanatory notes, two diagnostic pseudo M/A plots and Table S1, a summary of all the relative abundance ratios for internalized/control P. gingivalis mentioned in this report. Prior to permanent archiving at LANL with the raw mass spectral data, summaries of the ATCC 33277-based protein identifications in the form of DTASelect filter.txt files will be available on a University of Washington server http://​depts.​washington.​edu/​mhlab/​, rather than on the BMC Microbiology web site due to their large size. Request a password from the corresponding author.

BIE cells were plated at 3×104 cells/well of a 12-well ptype I collagen-coated plates (Iwaki, Tokyo, Japan), and cultured for three days. After changing medium, lactobacilli (5×107

cells/ml) were added and 48 hours later, each well was washed vigorously with medium at least 3 times to eliminate all the stimulants. Expression of cytokines, chemokines and TLRs negative regulators were studied first without any Selleckchem AZD1080 inflammatory challenge by using real time PCR as described below. 3-MA molecular weight In addition, the effect of lactobacilli on BIE cells immune response was studied using heat-stable ETEC as inflammatory factor. BIE cells were treated with heat-stable ETEC (final concentration: 5×107 cells/ml) for indicated time and the expression of cytokines, chemokines and TLRs negative regulators were studied by using real time PCR as described below. In addition, activation of p38, c-Jun N-terminal kinase (JNK) and

extracellular signal-regulated kinase (ERK) mitogen-activated protein kinases and NF-кB pathways were studied by using western blotting as described Adenosine triphosphate below. In these experiments, the synthetic TLR2 agonist PS-341 clinical trial tripalmitoylated lipopeptide Pam3CysSerLys4 (Pam3CSK4) was also used. BIE cells were stimulated with Pam3CSK4 (final concentration: 200 ng/ml) for the indicated time same as the other stimuli. Quantitative expression analysis of cytokines, chemokines and TLRs negative

regulators by PCR in BIE cells Two-step real-time quantitative PCR was used to characterize the expression of cytokines, chemokines and TLRs negative regulators mRNAs in BIE cells. Total RNA from each sample was isolated from the BIE cells using TRIzol reagent (Invitrogen). All cDNAs were synthesized from 5 μg of total RNA using a Quantitect Reverse Transcription kit (Qiagen, Tokyo, Japan) according to the manufacturer’s recommendations. Real-time quantitative PCR was carried out using a 7300 Real-time PCR System (Applied Biosystems, Warrington, UK) using Platinum SYBR Green qPCR SuperMix UDG with ROX (Invitrogen). The primers for cytokines, chemokines and TLRs negative regulators used in this study are described in Table 1.

CrossRef 5. Stolt L, Hedstrom J, Kessler J, Ruckh M, Velthaus KO, Schock HW: ZnO/CdS/CuInSe 2 thin‒film solar cells with improved performance. Appl Phys Lett 1993, 62:597–599.CrossRef 6. Lupan O, Pauporté T, Le Bahers T, Viana

B, Ciofini I: Wavelength‒emission tuning of ZnO nanowire‒based light‒emitting diodes by Cu doping: experimental and computational insights. Adv Funct Mater 2011, XAV-939 21:3564–3572.CrossRef 7. Jiang S, Ren Z, Gong S, Yin S, Yu Y, Li X, Xu G, Shen G, Han G: Tunable photoluminescence properties of well-aligned ZnO nanorod array by oxygen plasma post-treatment. Appl Surf Sci 2014, 289:252–256.CrossRef 8. Lin K-F, Cheng H-M, Hsu H-C, Hsieh W-F: Band gap engineering and spatial confinement of optical phonon in ZnO quantum dots. Appl Phys Lett 2006, 88:263113–263117.CrossRef 9. Wang ZL: Zinc oxide nanostructures: growth, properties and applications. Condens Matter Phys 2004, 16:829–857.CrossRef 10. Choi MY, Choi D, Jin MJ, Kim I, Kim SH, Choi learn more JY, Lee SY, Kim

JM, Kim SW: Mechanically powered transparent flexible charge‒generating nanodevices with piezoelectric ZnO nanorods. Adv Mater 2009, 21:2185–2189.CrossRef 11. Huo K, Hu Y, Fu J, Wang X, Chu PK, Hu Z, Chen Y: Direct and large-area growth of one-dimensional ZnO GSK621 manufacturer nanostructures from and on a brass substrate. J Phys Chem C 2007, 111:5876–5881.CrossRef 12. Snure M, Tiwari A: Band-gap engineering of Zn 1-x Ga x O nanopowders: synthesis, structural selleck chemicals and optical characterizations. J Appl Phys 2008, 104:073707–5.CrossRef 13. Wang X, Song C, Geng K, Zeng F, Pan F: Photoluminescence and Raman scattering of Cu-doped ZnO films prepared by magnetron sputtering. Appl Surf Sci 2007, 253:6905–6909.CrossRef 14. Zhang Z, Yi JB, Ding J, Wong LM, Seng HL, Wang SJ, Tao JG, Li GP, Xing GZ, Sum TC: Cu-doped ZnO nanoneedles and nanonails: morphological evolution and physical properties. J Phys Chem C 2008, 112:9579–9585.CrossRef 15. Ding J, Chen H, Zhao X, Ma S: Effect of substrate and annealing on the structural and optical properties of ZnO:Al films. J Phys Chem Solids 2010, 71:346–350.CrossRef 16. Muthukumaran S, Gopalakrishnan R: Structural, FTIR and photoluminescence studies of Cu doped ZnO nanopowders by co-precipitation

method. Opt Mater 2012, 34:1946–1953.CrossRef 17. Yamada T, Miyake A, Kishimoto S, Makino H, Yamamoto N, Yamamoto T: Effects of substrate temperature on crystallinity and electrical properties of Ga-doped ZnO films prepared on glass substrate by ion-plating method using DC arc discharge. Surf Coat Technol 2007, 202:973–976.CrossRef 18. Lupan O, Pauporté T, Viana B, Aschehoug P: Electrodeposition of Cu-doped ZnO nanowire arrays and heterojunction formation with p-GaN for color tunable light emitting diode applications. Electrochim Acta 2011, 56:10543–10549.CrossRef 19. Dingle R: Luminescent transitions associated with divalent copper impurities and the green emission from semiconducting zinc oxide. Phys Rev Lett 1969, 23:579–581.CrossRef 20.

PubMedCrossRef Foretinib 13. Klingberg TD, Pedersen MH, Cencic A, Budde BB: Application of measurements of transepithelial electrical resistance of intestinal epithelial

cell monolayers to evaluate probiotic activity. Appl Environ Microbiol 2005,71(11):7528–7530.PubMedCrossRef 14. Putaala H, Salusjarvi T, Nordstrom M, Saarinen M, Ouwehand AC, Bech-Hansen E, Rautonen N: Effect of four probiotic strains and Escherichia coli O157:H7 on tight junction integrity and cyclo-oxygenase expression. Res Microbiol 2008,195(9–10):692–698.CrossRef 15. Ewaschuk JB, Diaz H, Meddings L, Diederichs B, Dmytrash A, Backer J, Looijer-van Langen M, Madsen KL: Secreted bioactive factors from Bifidobacterium LY2874455 solubility dmso infantis enhance epithelial cell barrier function. Am J Physiol Gastrointest FK506 cell line Liver Physiol 2008,295(5):G1025–1034.PubMedCrossRef 16. Mennigen R, Nolte K, Rijcken EM, Utech M, Loeffler B, Senninger N, Bruewer M: Probiotic mixture VSL#3 protects the epithelial barrier by maintaining tight junction protein expression and preventing

apoptosis in a murine model of colitis. Am J Physiol Gastrointest Liver Physiol 2009,296(5):G1140–1149.PubMedCrossRef 17. Qin H, Zhang Z, Hang X, Jiang Y: L. plantarum prevents enteroinvasive Escherichia coli -induced tight junction proteins changes in intestinal epithelial cells. BMC Microbiol 2009, 9:63.PubMedCrossRef 18. Otte JM, Podolsky DK: Functional modulation of enterocytes by gram-positive and gram-negative Morin Hydrate microorganisms. Am J Physiol Gastrointest Liver Physiol 2004,286(4):G613–626.PubMedCrossRef 19. Shibolet O, Karmeli F, Eliakim R, Swennen E, Brigidi P, Gionchetti P, Campieri M, Morgenstern S, Rachmilewitz D: Variable response to probiotics in two models of experimental colitis in rats. Inflamm Bowel Dis 2002,8(6):399–406.PubMedCrossRef 20. Di Giacinto C, Marinaro M, Sanchez

M, Strober W, Boirivant M: Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-beta-bearing regulatory cells. J Immunol 2005,174(6):3237–3246.PubMed 21. Kim HJ, Camilleri M, McKinzie S, Lempke MB, Burton DD, Thomforde GM, Zinsmeister AR: A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther 2003,17(7):895–904.PubMedCrossRef 22. Bibiloni R, Fedorak RN, Tannock GW, Madsen KL, Gionchetti P, Campieri M, De Simone C, Sartor RB: VSL#3 Probiotic-Mixture Induces Remission in Patients with Active Ulcerative Colitis. Am J Gastroenterol 2005,100(7):1539–1546.PubMedCrossRef 23. Gionchetti P, Rizzello F, Venturi A, Brigidi P, Matteuzzi D, Bazzocchi G, Poggioli G, Miglioli M, Campieri M: Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 2000,119(2):305–309.PubMedCrossRef 24.

1∼0.9% point) in the percentage differences between Caucasian men vs each race/ethnic group except those at hip sites between Caucasian

men vs Korean men (1.9% point; Table 2). Discussion We compared hip and spine BMD in men of seven race/ethnic groups and five countries. Our results indicate that there are substantial differences in age-adjusted BMD across race/ethnic groups and countries. In age-adjusted analysis, total hip BMD distributed across Five strata: Afro-Caribbean men had the highest level; African-American men in the PLX4032 second; US Caucasian and US Hispanic in the third; US Asian and Hong Kong Chinese in the fourth; and Korean men had the lowest level. Although age-related change in osteophytic calcification might affect spine DXA measures, similar patterns were this website observed for lumbar spine BMD as well as femoral neck except for Korean men. Unlike total hip BMD, femoral LXH254 order neck BMD among Korean men was similar to Caucasian men. Identification of the BMD differences across race/ethnicity and geography has important implication for understanding geographic variability in fracture risk. In general, hip BMD is strongly associated with the risk of nonvertebral fracture in older men [29, 30]. Differences in age-adjusted BMD among Asian groups are consistent

with the wide variability in fracture rates across Asian countries in the Asian Osteoporosis Study (AOS) [31]. The reported hip fracture rate among Korean men aged 70 to 79 (325 per 105 men in 2004) [32] is slightly higher than Hong Kong Chinese men in AOS and is compatible with the difference in total hip BMD among both groups in our study. However, total hip BMD across some race/ethnic groups in our study is not compatible with previous reports [5–11]

showing that fracture rates are lower in US Hispanic and Asian men than in Caucasian men. This paradox in Asian men may be in part attributable to more favorable hip geometry (the shorter hip axis length and smaller neck shaft angle) [33] and bone structure (greater cortical thickness and trabecular volumetric BMD) [34] among this group than Caucasian men. In addition to these factors, different fall rates [35] across race/ethnic groups can be involved in that paradox. The differences in BMD depend both on genetic next and environmental factors across countries and race/ethnic groups [36]. The environmental factors include social factors, as well as lifestyle factors, that could influence BMD within each community. For example, the prominent differences in total hip BMD between Korean and other Asian groups suggest differences in lifestyle and social factors in part. As shown in Table 1, the lower amount of calcium intake in Korean men may contribute to the lower total hip BMD: The difference in total hip BMD between Korean and Hong Kong Chinese men was smaller after adding dietary calcium intake into the regression model including age, weight, and height as covariates.

In a farewell editorial, published in the final issue of the former selleck journal Community Genetics, Leo ten Kate likewise INCB018424 datasheet emphasized that community genetics “is not just a name but a unique concept, which has its own place besides clinical genetics and public health genetics or genomics” (ten Kate 2008, see also Schmidtke

and ten Kate 2010; and ten Kate et al. 2010). In this commentary, I will take a closer look at the uniqueness of the concept of community genetics, using the 11 volumes of the former journal Community Genetics as my primary source material.1 My aim is not a complete review of the contents of this journal, which would be an impossible task,

but a discussion of some aspects and questions which I see as particularly interesting and significant for our understanding of the concept and agenda of community genetics. What can we learn from the history contained in this former journal about the particularities of community genetics and its relation with the emerging field of public health genomics? Most revealing in this history is the tension between a conception of community genetics as a professional and regulated endeavour and as a programme of individual empowerment. Although we can see this tension as a unique feature following from the concept and agenda of community genetics, it is also highly significant, as I will argue, for the STAT inhibitor future prospects of public health genomics. The agenda of community genetics The ambitions of community genetics as a field can be defined in terms of four movements Celastrol or shifts which characterize the activities of its practitioners as distinct from the traditional practices of clinical geneticists

(ten Kate 1998; Brisson 2000). The first of these movements is a shift in focus away from individuals to populations, bringing genetic services to the community as a whole. Implied by this movement is a shift from people with symptoms to people without symptoms, whereby the initiative is coming from the care system. The third movement is a shift from reproductive choice as a main focus to options for prevention of disease, and, in relation to this movement, we might also mention a fourth shift, from rare monogenetic disorders to multi-factorial forms of common diseases. This latter shift, however, seems at present more a prospect than reality (ten Kate 2001; Brand et al. 2006). Although the first two shifts are clearly defining the agenda of community genetics, it is the third shift—from reproductive choice to prevention of disease—which brings us to a question that is most revealing and significant for the ambitions of the field.

The number of EPCs was expressed per 1 mlblood [22]. Figure 1 Characterization of endothelial progenitor cells (EPCs) by flowcytometry evaluation. First, cells were plotted in forward vs side scatter to gate the lymphocyte population selectively, where EPCs are usually found (a). For analysis of CD45dimCD34+KDR+ endothelial progenitor cells, CD45 was then plotted against the side scatter (b), followed by further analysis Enzalutamide concentration of the CD45dim population on coexpression of CD34/KDR (c). Nitrite and leptin measurement Mice were

fasted for 14 h prior to sacrificing in order to obtain fasted blood samples. Plasma was isolated from whole blood collected and total nitrite (NOx) was measured (R&D Systems) as an indicator of endothelial release of NO as previously described [23]. Moreover, plasma leptin concentration was measured by ELISA kit (R&D Systems) in mice according to manufacturer’s instructions. Statistical analysis Data are expressed as mean ± SD and were tested for normal distribution with the Kolmogorov-Smirnov test.

Comparisons between groups were analysed by ANOVA followed by the Bonferroni method as post hoc-test. Differences in the weight of the mice were analyzed using the paired-sample t test. Statistical significance was assumed, if a null hypothesis could be click here rejected at p ≤ 0.05. All statistical analysis was performed with SPSS 16 (SPSS Inc.). Results The plasma levels of leptin were significantly higher in leptin group compared to all other groups of mice while there was

no significant difference between other groups (Figure 2). Figure 2 The plasma levels of leptin were significantly higher in leptin group compared Tacrolimus (FK506) to all other groups of mice while there was no significant difference between other groups. * (p < 0.05). Body GSK3326595 manufacturer weights for each group of mice are shown in Table 1. There was a significant weight loss in mice of leptin group while the weight of the animals of 9F8 group increased significantly during the study. By the end of the experiment there was a significant difference between leptin and 9f8 group in body weight and also between each group and its relevant control group. Table 1 The weight of mice in each group of the study. group Mice weight1 Mice weight2 P(before-after) IgG 23.41 ± 0.31 23.24 ± 0.479 p > 0.05 9f8 22.74 ± 0.30 25.37 ± 0.77* P < 0.05 leptin 22.68 ± 0.99 19.25 ± 1.53*γ P < 0.05 PBS 24.37 ± 1.22 24.60 ± 1.20 p > 0.05 *Significant difference with respective control group γ Significant difference with 9F8 group The melanoma tumor weight of leptin treated mice were significantly more than tumors from other groups of mice while there was no significant difference between other groups (Figure 3). Figure 3 Mean tumors size and weight. The weights and volume of melanoma tumors excised from leptin treated mice were significantly larger than tumors from other groups of mice. There was no significant difference between three other study groups. * (p < 0.05).

Six cases had pulmonary metastases during follow up, two of which underwent surgical resection Selleckchem SBE-��-CD and four had chemotherapy. Evaluation of Ki-67 immuno-histochemical expression Expression of Ki-67 antigen was evaluated by immuno-histochemical staining in all representative sections from each patient. Serial sections, 5 μm thick, were cut and immuno-histochemical techniques were carried out using the avidin-biotin perioxidase complex method using an LSAB2 kit (Dako, Glostrup, Denmark). The primary antibody used in this study was Ki-67 (MIB-I clone, dilution 1:25; Dako). Expression of proliferation index

marker Ki-67 in the nuclear area of the tumor cells were examined using immuno-histochemistry. The labeled-cell count (Ki-67 proliferation index) was determined in ten high-power fields by two blinded observers. Ki-67 proliferation index was defined as the ratio of labeled cells to total cells. Statistical analysis All data obtained were analysed by using SPSS 12.0.1 software. Statistical analysis between different group were determined using independent t-test and considered statistically significant when the p values were less than 0.05. Results The staining was confined to the nuclei of the stromal cells in all cases. The mean value

of Ki-67 index obtained as a percentage of 1000 background cells was 8.15 (range 1.00 – 20.0). The median Ki-67 index was 7.5 with standard deviation of 5.12. The Ki-67 index of recurrent tumor was 4.323 as compared

to 6.05 Selleckchem Idasanutlin without recurrence and was not statistically significant (mean difference selleck chemical of 0.865 with 0.736 of p value in independent t test). The Ki-67 index Interleukin-2 receptor was also not statistically significant in those with pulmonary metastases with the mean value of 6.68 with metastatic group as compared to 2.89 of those without metastases (mean difference of 1.895 with 0.424 of p value in independent t test). In the recurrent tumors with pulmonary metastasis, Ki-67 index was 6.40 when compared with 2.20 in disease free cases. The mean difference was 2.099 with p value of 0.326 and was not statistically significant. Discussion Stage III or aggressive giant cell tumor is defined as symptomatic, rapidly growing lesion that is often associated with spontaneous fracture [2, 3]. GCT is an infrequent and unpredictable bony lesion, and in our series it was not only presented with locally aggressive behaviour, but it also had higher incidence of local recurrent and pulmonary metastasis [4, 5]. Various proliferation markers had been studied to correlate with the aggressive behaviour of GCT and surgical outcome. These included the expression of Ki 67, proliferating cell nuclear antigen, p 53 tumor suppressor gene, matrix metalloproteinase (MMP)-1/9, parathyroid hormone-like protein (PTH-LP) in the mononuclear histiocytic stromal cell.

europaea [16]. NsrR is responsible for sensing NO and NO2 – concentrations and is supposedly involved in MK-0518 the transcriptional regulation of several operons including the nirK gene cluster

of N. europaea [9]. Although N. europaea contains norB, alternate pathways are possibly involved in the production of N2O [7], the increased transcription of norB, shown in this study cannot be unequivocally reconciled with functional N2O production. Nevertheless, the increased transcription of both nirK and norB in response to high nitrite concentrations is in keeping with one of our initial hypotheses. The uniformly lower transcript concentrations upon growth with added 280 mg NO2 –N/L could be a result of

energy resources channeled towards mitigation of nitrite toxicity rather than its utilization as an electron acceptor during stationary phase. In general, it could be argued that in response to nitrite toxicity during ammonia starvation, there is little incentive to increase transcription of putative nitrite and nitric oxide reduction pathways. However, it should be noted that the lower transcript abundance during MK 2206 stationary phase when grown with added 280 mg NO2 –N/L is in direct contrast to an increase in nirK during stationary phase, when grown without added NO2 –N (Figure 3 B4-C4). The more gradual build-up of nitrite in the latter case could have see more allowed for adaptation, whereas the initial spike of 280 mg NO2 –N/L might have imposed a significant toxic stress that resulted in reduced growth and different transcriptional profiles. Indeed, the toxic stress was possibly too severe at 560 mg NO2 –N/L, which resulted in no growth whatsoever. Additionally, the reduction in transcript abundance of amoA and hao in the presence of NO2 –N, did not parallel the relatively unchanged sOUR in the presence or absence of NO2 –N. Given that sOUR is a measure of the sum of AMO and HAO activities, these results also suggest uncoupling of the responses at the gene transcription and post-transcriptional or translational levels (Figure 4). Responses at the protein abundance

Rutecarpine and activity levels would be needed to substantiate and provide an explanation for such uncoupling. It should be noted that the severe impacts of added nitrite were possibly related to the application of these high nitrite concentrations at the beginning of the batch growth assays. Had the nitrite concentrations been applied during periods of relatively higher cell concentrations (during exponential or stationary phase), the impacts might have been less severe, given that the cells were already producing and responding to the increasing NO2 –N levels in the culture medium. Thus, in a sense, the results reported herein represent the most extreme response of N. europaea cultures to nitrite exposure. Conclusions The responses of N.

As previously reported [2, 6, 7], patients who were less healthy due to an increased age, comorbidities or those with known treatment failure risk factors, were significantly more likely to fail antibiotic therapy. These same features independently increased hospitalization costs. Therefore, illness severity must be strongly considered when choosing starting empirical antibiotic therapy, due to its influence on clinical and economic outcomes of patients with cIAIs. The low rate of intra-operative microbiology tests performed in the present study is worrisome. As choosing antibiotics for the treatment of cIAIs is an empiric

decision, local epidemiology knowledge is of outmost importance. By increasing the chance of appropriate treatment [1], it could improve outcome and decrease resource utilization in patients subsequently hospitalized in the same institution for the same IBET762 condition. Thus, we recommend that the consistent taking of swab samples by this website Italian surgeons is implemented. As with any retrospective analysis,

this study has several limitations. Due to complexities associated with the collection of data, summary measures of illness and comorbidities severity, potentially associated with clinical failure, longer length of hospital stay, and higher inpatient costs were not covered and could not be used in the multivariate model. We were also unable to assess the appropriateness of antibiotic therapy in light AZD9291 of culture results and patient clinical risk profile [1, 9] and, therefore,

the clinical failure variable, rather than antibiotic appropriateness, was used in the multivariable analysis of independent cost predictors. Finally, being a multicenter study, dissimilarity in standard Carnitine dehydrogenase of care among participating sites cannot be excluded. Despite these limitations, for the first time we assessed patterns of starting antibiotic therapy, resource utilization and actual costs of caring for inpatients with community-acquired cIAIs in Italian hospitals. The results of this study suggest that hospitals need to be aware of the clinical and economic consequences of antibiotic therapy and to reduce overall resource use and costs by improving the rate of success with appropriate initial empiric therapy. Considering the prospective reimbursement system of the Italian NHS, there may be a relevant cost saving at the same reimbursement rate for hospitals, by reducing antibiotic costs of cIAIs. Mandatory peritoneal swab sampling, allowing for local epidemiology driven empiric antibiotic therapy, should be strongly encouraged for each cIAIs patient. Acknowledgements The authors would like to thank Simone Boniface of Springer Healthcare Communications, who edited the manuscript for English and styled for submission. This medical writing assistance was funded by Pfizer. References 1.